Each of the CG genes (MAGEA1, NY-ESO1, and XAGE1) that James et al. assessed was not substantially expressed in benign prostate cell lines but was heterogeneously expressed in prostate cancer cell lines [24]. Here, MAGEA1 is linked to urogenital neoplasm.